Skip to main content
CGEM logo

CGEM · Cullinan Therapeutics, Inc.

$17.21 -0.27 (-1.52%) At close · Jul 29
Market Cap
$1.07B
Shares
61.46M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Nadim Ahmed $5,100,006
Jeffrey Jones $2,221,578
Mary Kay Fenton $2,078,837
Fiscal 2024
Executive Total
Nadim Ahmed $7,684,366
Mary Kay Fenton $4,142,413
Jeffrey Trigilio $4,002,434
Jeffrey Jones $3,388,014
Fiscal 2023
Executive Total
Nadim Ahmed $4,008,206
Jeffrey Jones $2,421,669
Jeffrey Trigilio $2,204,333
Fiscal 2022
Executive Total
Nadim Ahmed $3,900,527
Patrick Baeuerle $1,959,984
Jeffrey Trigilio $1,924,274
Fiscal 2021
Executive Total
Nadim Ahmed $38,547,200
Owen Hughes $6,786,187
Patrick Baeuerle $4,675,977
Jeffrey Trigilio $2,667,635
Fiscal 2020
Executive Total
Owen Hughes $6,552,058
Patrick Bauerle $5,353,497
Patrick Baeuerle $5,353,496
Jon Wigginton $4,544,022
Fiscal 2019
Executive Total
Patrick Bauerle $562,797
Owen Hughes $560,800
Key facts CIK 1789972 CUSIP 230031106 13F (30d) 25 filings 25 filers Visit website Investor relations